Stem cell research takes a step toward smart blood sugar control in diabetes

Professor Deng Hongkui's team from the Peking University School of Life Sciences has made the first successful differentiation of human pluripotent stem cells into fully endocrine-subtype-complete islets.

Their findings have been published in Cell Stem Cell in a paper titled “Reconstruction of endocrine subtype-complete human pluripotent stem cell-derived islets with capacity for hypoglycemia protection in vivo.”

Transplantation of pluripotent stem cell-derived islets (PSC-islets) represents a promising therapy for restoring blood sugar control in diabetes, owing to the self-renewal and differentiation capacities of PSCs, overcoming the problem of scarcity of cadaveric islets required for islet transplantation.

This research has succeeded for the first time in the challenging task of reconstruction of PSC-islets comprising all five (α, β, δ, ε, and γ) endocrine subtypes.

Sign up for Blog Updates